Thus, it seems that DSIP may indeed play a role in altering physiology in preparation of the body for sleep, as some of it effects occur before neurological and behavioral signs of sleep
Data from longer-term treatment will therefore be eagerly awaited to determine the extent of body weight loss and metabolic outcomes and whether this is comparable to the latest GLP-1 mono-agonist therapies
GLP-1RAs provide different mechanistic effects including anti-oxidative, anti-inflammatory, and anti-atherosclerotic properties [4, 9, 11, 14, 17]
Studies show BPC-157 accelerates healing through multiple mechanisms: increased angiogenesis (new blood vessel formation) by 129-152%, enhanced collagen synthesis, reduced inflammation, and faster re-epithelialization